Literature DB >> 16627934

Thrombin and inflammatory proteins are elevated in Alzheimer's disease microvessels: implications for disease pathogenesis.

Paula Grammas1, Pezhman Ghatreh Samany, Lakshmi Thirumangalakudi.   

Abstract

The notion that microvascular abnormalities contribute to deleterious changes in the Alzheimer's disease (AD) brain is supported by work from our laboratory and others demonstrating biochemical and functional alterations of the microcirculation in AD. The objective of this study is to determine whether levels of neurotoxic (thrombin) and inflammatory (interleukin 8 (IL-8), integrins alphaVbeta3 and alphaVbeta5) proteins are altered in microvessels isolated from AD patients compared to levels in vessels obtained from non-demented age-matched controls. We also evaluate in AD and control microvessels expression of the transcription factor hypoxia-inducible factor 1-alpha(HIF1-alpha), which regulates pro-inflammatory gene expression, and the regulation of HIF1-alpha expression by thrombin in cultured brain endothelial cells. Our results indicate that in AD there are high levels of expression of the neurotoxic protease thrombin and the inflammation-associated proteins IL-8 and alphaVbeta3 and alphaVbeta5 integrins. HIF1-alpha is higher in AD microvessels compared to control and thrombin treatment of cultured brain endothelial cells results in increased expression of HIF1-alpha. These data suggest that in AD the cerebral microcirculation is a source of neurotoxic and inflammatory mediators and as such contributory to pathologic processes ongoing in the AD brain.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16627934     DOI: 10.3233/jad-2006-9105

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  55 in total

1.  Oxidative stress impairs learning and memory in apoE knockout mice.

Authors:  Marianne Evola; Allyson Hall; Trevor Wall; Alice Young; Paula Grammas
Journal:  Pharmacol Biochem Behav       Date:  2010-05-08       Impact factor: 3.533

Review 2.  The role of inflammatory processes in Alzheimer's disease.

Authors:  G Joseph Broussard; Jennifer Mytar; Rung-chi Li; Gloria J Klapstein
Journal:  Inflammopharmacology       Date:  2012-04-26       Impact factor: 4.473

3.  Associations of impaired behaviors with elevated plasma chemokines in autism spectrum disorders.

Authors:  Paul Ashwood; Paula Krakowiak; Irva Hertz-Picciotto; Robin Hansen; Isaac N Pessah; Judy Van de Water
Journal:  J Neuroimmunol       Date:  2010-11-20       Impact factor: 3.478

Review 4.  Vascular basis for brain degeneration: faltering controls and risk factors for dementia.

Authors:  Raj N Kalaria
Journal:  Nutr Rev       Date:  2010-12       Impact factor: 7.110

5.  RANTES upregulation in the Alzheimer's disease brain: a possible neuroprotective role.

Authors:  Debjani Tripathy; Lakshmi Thirumangalakudi; Paula Grammas
Journal:  Neurobiol Aging       Date:  2008-04-28       Impact factor: 4.673

Review 6.  Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.

Authors:  Livius V d'Uscio; Tongrong He; Zvonimir S Katusic
Journal:  Physiology (Bethesda)       Date:  2017-01

Review 7.  Impairing the mitochondrial fission and fusion balance: a new mechanism of neurodegeneration.

Authors:  Andrew B Knott; Ella Bossy-Wetzel
Journal:  Ann N Y Acad Sci       Date:  2008-12       Impact factor: 5.691

8.  Inhibition of protease-activated receptor 1 (PAR1) ameliorates cognitive performance and synaptic plasticity impairments in animal model of Alzheimer's diseases.

Authors:  Daruoosh Zare; Mohammad Amin Rajizadeh; Marzieh Maneshian; Hossein Jonaidi; Vahid Sheibani; Majid Asadi-Shekaari; Manouchehr Yousefi; Khadijeh Esmaeilpour
Journal:  Psychopharmacology (Berl)       Date:  2021-02-23       Impact factor: 4.530

9.  Cerebrovascular expression of proteins related to inflammation, oxidative stress and neurotoxicity is altered with aging.

Authors:  Debjani Tripathy; Xiangling Yin; Alma Sanchez; Jinhua Luo; Joseph Martinez; Paula Grammas
Journal:  J Neuroinflammation       Date:  2010-10-11       Impact factor: 8.322

Review 10.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.